$8.00
-0.02-0.25%
At Close: -
$8.18
0.182.25%
After Hours: Sep 12, 7:47 AM EDT
15 minutes delayed
Comments
Loading...
Actuate Therapeutics (ACTU) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestActuate Therapeutics (NASDAQ:ACTU) Stock Quotes, Forecast and News Summary
Actuate Therapeutics Stock (NASDAQ: ACTU) stock price, news, charts, stock research, profile.
| Open | $8.02 |
| Close | $8.00 |
| Volume / Avg. | 11.72K / 42.63K |
| Day Range | $8.00 - $8.23 |
| 52 Wk Range | 7.33 - 10.16 |
| Market Cap | $156.33M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 43 |
| Short Interest | - |
| Days to Cover | 1 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Actuate Therapeutics Inc.
Sector
Health Care
Industry
Biotechnology
Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapi...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Actuate Therapeutics (ACTU) stock?
You can purchase shares of Actuate Therapeutics (NASDAQ:ACTU) through any online brokerage.
Who are Actuate Therapeutics (ACTU) competitors?
Other companies in Actuate Therapeutics’s space includes: Molecular Partners (NASDAQ:MOLN), Outlook Therapeutics (NASDAQ:OTLK), Innate Pharma (NASDAQ:IPHA), Skye Bioscience (NASDAQ:SKYE) and Galectin Therapeutics (NASDAQ:GALT).
What is the forecast, or price target, for Actuate Therapeutics (ACTU) stock?
There is no analysis for Actuate Therapeutics to provide a consensus price target.
What is the current price for Actuate Therapeutics (ACTU)?
The stock price for Actuate Therapeutics (NASDAQ: ACTU) is $8 last updated September 18, 2024 at 4:00 PM EDT.
Does Actuate Therapeutics (ACTU) pay a dividend?
There are no upcoming dividends for Actuate Therapeutics.
When is Actuate Therapeutics (NASDAQ:ACTU) reporting earnings?
Actuate Therapeutics’s Q3 earnings are confirmed for Thursday, November 21, 2024.
Is Actuate Therapeutics (ACTU) going to split?
There is no upcoming split for Actuate Therapeutics.
What sector and industry does Actuate Therapeutics (ACTU) operate in?
Actuate Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.